Walter Goldstein, PhD., MBA, P.E. will talk about his patented method of creating a universal blood supply using bioreactors. He has co-founded a company, TransCyte, Inc. to develop the technology,
Tuesday, December 11th at 11:30 AM Check-in/Networking 12 PM Lunch
McCormick & Schmicks: Lunch $30. 355 Howard Hughes Parkway, Las Vegas, NV
R.S.V.P. Judith Lynn Rebholz 839-7201 or jrebholz@cvbt.com
Tuesday, December 11th at 11:30 AM Check-in/Networking 12 PM Lunch
McCormick & Schmicks: Lunch $30. 355 Howard Hughes Parkway, Las Vegas, NV
R.S.V.P. Judith Lynn Rebholz 839-7201 or jrebholz@cvbt.com
Dr. Walter E. Goldstein is the former Coordinator of the UNLV Biotechnology Center. He is the co-founder of TransCyte, Inc. (a company formed to produce red cells from stem cells) as well as the President of Goldstein Consulting Company. He has led a research and development organization of 140 persons (35 Ph.D.'s) at Bayer (Miles, Inc.), a leading firm in biotechnology, clinical diagnostics, therapeutics, food ingredients, materials, chemicals, and consumer products. He led 35 persons (10 Ph.D.'s) at ESCAgenetics Corporation, which was a leading developer of plant-based technology for food, food ingredients and pharmaceuticals. He designed and developed cryogenic processes and equipment for Union Carbide Corporation. At the UNLV Biotechnology center he developed programs in forensic DNA profiling, microbiological identification, food safety, genetic basis for biotechnology improvements, and prevention of nosocomial infections.
Dr. Walter Goldstein holds a BS in chemical engineering from the Illinois Institute of Technology, an MS and PhD in chemical engineering from the University of Notre Dame, and an MBA from Michigan State University, with emphasis in finance, marketing, business law, and business organization. He is a Registered Professional Engineer. He has held faculty and research appointments in both the University (Notre Dame, UNLV) and private sectors.
Dr. Goldstein holds a number of patents including the process for producing a transfusable, oxygenating composition of human red blood cells by the ex vivo culturing, expansion and differentiation of human primitive hematopoietic cells. The process involves expansion of primitive hematopoietic cells in a first bioreactor containing one or more growth factors, differentiating the cells into erythroid progenitor cells in a second bioreactor containing one or more differentiation factors and effecting maturation of the erythroid progenitor cells into mature erythrocytes in a third bioreactor containing one or more maturation factors. The invention also provides a process for producing a transfusable, oxygenating composition of red blood cells by expansion and differentiation of primitive hematopoietic cells in a bioreactor containing a nutrient medium which includes perfluorocarbons which improve the exchange of oxygen and carbon dioxide between the cells and the nutrient media.
Dr. Walter Goldstein holds a BS in chemical engineering from the Illinois Institute of Technology, an MS and PhD in chemical engineering from the University of Notre Dame, and an MBA from Michigan State University, with emphasis in finance, marketing, business law, and business organization. He is a Registered Professional Engineer. He has held faculty and research appointments in both the University (Notre Dame, UNLV) and private sectors.
Dr. Goldstein holds a number of patents including the process for producing a transfusable, oxygenating composition of human red blood cells by the ex vivo culturing, expansion and differentiation of human primitive hematopoietic cells. The process involves expansion of primitive hematopoietic cells in a first bioreactor containing one or more growth factors, differentiating the cells into erythroid progenitor cells in a second bioreactor containing one or more differentiation factors and effecting maturation of the erythroid progenitor cells into mature erythrocytes in a third bioreactor containing one or more maturation factors. The invention also provides a process for producing a transfusable, oxygenating composition of red blood cells by expansion and differentiation of primitive hematopoietic cells in a bioreactor containing a nutrient medium which includes perfluorocarbons which improve the exchange of oxygen and carbon dioxide between the cells and the nutrient media.
3 comments:
Hey,
When ever I surf on web I never forget to visit this website[url=http://www.weightrapidloss.com/lose-10-pounds-in-2-weeks-quick-weight-loss-tips].[/url]You have really contiributed very good info here nevbio.blogspot.com. Do you pay attention towards your health?. Let me present you with one fact here. Research points that nearly 60% of all USA adults are either fat or weighty[url=http://www.weightrapidloss.com/lose-10-pounds-in-2-weeks-quick-weight-loss-tips].[/url] So if you're one of these citizens, you're not alone. In fact, most of us need to lose a few pounds once in a while to get sexy and perfect six pack abs. Now the question is how you are planning to have quick weight loss? [url=http://www.weightrapidloss.com/lose-10-pounds-in-2-weeks-quick-weight-loss-tips]Quick weight loss[/url] is really not as tough as you think. If you improve some of your daily diet habbits then, its like piece of cake to quickly lose weight.
About me: I am author of [url=http://www.weightrapidloss.com/lose-10-pounds-in-2-weeks-quick-weight-loss-tips]Quick weight loss tips[/url]. I am also health trainer who can help you lose weight quickly. If you do not want to go under difficult training program than you may also try [url=http://www.weightrapidloss.com/acai-berry-for-quick-weight-loss]Acai Berry[/url] or [url=http://www.weightrapidloss.com/colon-cleanse-for-weight-loss]Colon Cleansing[/url] for fast weight loss.
x8e67y8g09 z5p64u2b47 f8e88z6b30 c9w27t2f48 y0r97q3m36 l0u38l2f32
x0j96z9s94 o9r89u0u85 i9j79d9b24 r3g68q6q67 d2a53w2z71 v5r65l5x50
Post a Comment